Raed Alhusayen MBBS, MSc (Co-Chair) , Serena Dienes BSc , Megan Lam MD , Afsaneh Alavi MD , Ali Alikhan MD , Maria Aleshin MD , Emad Bahashwan MD , Steve Daveluy MD , Noah Goldfarb MD , Amit Garg MD , Wayne Gulliver MD , Tarannum Jaleel MD, MHSc , Alexa B. Kimball MD, MPH , Mark G. Kirchhof MD, PhD , Joslyn Kirby MD, MS, MEd , Joi Lenczowski MD , Hadar Lev-Tov MD, MAS , Michelle A. Lowes MBBS, PhD , Irene Lara-Corrales MD, MSc , Robert Micheletti MD , Haley B. Naik MD, MHSc (Co-Chair)
{"title":"North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations","authors":"Raed Alhusayen MBBS, MSc (Co-Chair) , Serena Dienes BSc , Megan Lam MD , Afsaneh Alavi MD , Ali Alikhan MD , Maria Aleshin MD , Emad Bahashwan MD , Steve Daveluy MD , Noah Goldfarb MD , Amit Garg MD , Wayne Gulliver MD , Tarannum Jaleel MD, MHSc , Alexa B. Kimball MD, MPH , Mark G. Kirchhof MD, PhD , Joslyn Kirby MD, MS, MEd , Joi Lenczowski MD , Hadar Lev-Tov MD, MAS , Michelle A. Lowes MBBS, PhD , Irene Lara-Corrales MD, MSc , Robert Micheletti MD , Haley B. Naik MD, MHSc (Co-Chair)","doi":"10.1016/j.jaad.2024.11.071","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Hidradenitis suppurativa (HS) affects different patient populations that require unique considerations in their management. However, no HS guidelines for these populations exist.</div></div><div><h3>Objective</h3><div>To provide evidence-based consensus recommendations for patients with HS in 7 special patient populations: (i) pregnancy, (ii) breastfeeding, (iii) pediatrics, (iv) malignancy, (v) tuberculosis infection, (vi) hepatitis B or C infection, and (vii) HIV disease.</div></div><div><h3>Methods</h3><div>Recommendations were developed using the Grading of Recommendations Assessment, Development, and Evaluation system to ascertain level of evidence and selected through a modified Delphi consensus process.</div></div><div><h3>Results</h3><div>One hundred eighteen expert consensus statements are provided for the management of patients with HS across these 7 special patient populations.</div></div>","PeriodicalId":17198,"journal":{"name":"Journal of the American Academy of Dermatology","volume":"92 4","pages":"Pages 825-852"},"PeriodicalIF":12.8000,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Academy of Dermatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0190962224033954","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Hidradenitis suppurativa (HS) affects different patient populations that require unique considerations in their management. However, no HS guidelines for these populations exist.
Objective
To provide evidence-based consensus recommendations for patients with HS in 7 special patient populations: (i) pregnancy, (ii) breastfeeding, (iii) pediatrics, (iv) malignancy, (v) tuberculosis infection, (vi) hepatitis B or C infection, and (vii) HIV disease.
Methods
Recommendations were developed using the Grading of Recommendations Assessment, Development, and Evaluation system to ascertain level of evidence and selected through a modified Delphi consensus process.
Results
One hundred eighteen expert consensus statements are provided for the management of patients with HS across these 7 special patient populations.
期刊介绍:
The Journal of the American Academy of Dermatology (JAAD) is the official scientific publication of the American Academy of Dermatology (AAD). Its primary goal is to cater to the educational requirements of the dermatology community. Being the top journal in the field, JAAD publishes original articles that have undergone peer review. These articles primarily focus on clinical, investigative, and population-based studies related to dermatology. Another key area of emphasis is research on healthcare delivery and quality of care. JAAD also highlights high-quality, cost-effective, and innovative treatments within the field. In addition to this, the journal covers new diagnostic techniques and various other topics relevant to the prevention, diagnosis, and treatment of skin, hair, and nail disorders.